Skapyak Bradley J's Form 4 filing
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (DCF) · filed Feb 8, 2023
- Accession no.
- 0001627854-23-000001
- Filed
- Feb 8, 2023
- Trade date
- Dec 28, 2022
- Filing delay
- 42 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $10.0K. It was filed 42 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Skapyak Bradley JCIK 0001465389 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2022 | Common Stock, Par Value $.001 Per Share | PPurchaseAcquired | +1,414 | $7.07F1 | +$9,996.98 | 1,414 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in thirteen transactions at prices ranging from $7.065 to $7.07 inclusive. The reporting person undertakes to provide BNY Mellon Investment Adviser, Inc. or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.